1.
Chinese Journal of Urology
; (12): 39-42, 2021.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-911172
RESUMO
Conclusion:Patients with OlimHSPC who are not sensitive to traditional CAB treatment, ADT combined with abiraterone acetate neoadjuvant therapy and postoperative adjuvant therapy can be attempted.